IDH MUTATION

Clinical trials for IDH MUTATION explained in plain language.

Never miss a new study

Get alerted when new IDH MUTATION trials appear

Sign up with your email to follow new studies for IDH MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1

Drug duo targets Hard-to-Treat IDH-Mutated tumors

Disease control Ongoing

This phase 2 trial tests whether combining two drugs—olaparib and durvalumab—can shrink or control solid tumors that have an IDH mutation. The study includes adults with certain brain tumors (glioma) or bile duct cancer (cholangiocarcinoma) that have not responded well to prior t…

Matched conditions: IDH MUTATION

Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

IDH MUTATION

Get alerted when new IDH MUTATION trials appear

Drug duo targets Hard-to-Treat IDH-Mutated tumors